Bleeding risks with prasugrel in the TRITON trial: Good news... bad news

被引：7
作者：
Serebruany, Victor L. [1 ]
机构：
[1] Johns Hopkins Univ, HeartDrug Res Labs, Baltimore, MD 21204 USA
来源：
CARDIOLOGY | 2008年 / 111卷 / 04期
关键词：
D O I：
10.1159/000127750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：265 / 267
页数：3
相关论文
共 9 条
[1]  
Cannon CP, 1998, CIRCULATION, V97, P340
[2]   Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial [J].
Cannon, CP ;
McCabe, CH ;
Wilcox, RG ;
Langer, A ;
Caspi, A ;
Berink, P ;
Lopez-Sendon, J ;
Toman, J ;
Charlesworth, A ;
Anders, RJ ;
Alexander, JC ;
Skene, A ;
Braunwald, E .
CIRCULATION, 2000, 102 (02) :149-156
[3]   First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of the TIMI 15A and 15B trials [J].
Giugliano, RP ;
McCabe, CH ;
Sequeira, RF ;
Frey, MJ ;
Henry, TD ;
Piana, RN ;
Tamby, JF ;
Jensen, BK ;
Nicolas, SB ;
Jennings, LK ;
Wise, RJ ;
Braunwald, E .
AMERICAN HEART JOURNAL, 2000, 140 (01) :81-+
[4]   Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention - Results from the ARMYDA-2 (Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty) study [J].
Patti, G ;
Colonna, G ;
Pasceri, V ;
Pepe, LL ;
Montinaro, A ;
Di Sciascio, G .
CIRCULATION, 2005, 111 (16) :2099-2106
[5]  
RAO AK, 1988, J AM COLL CARDIOL, V11, P1
[6]   AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION [J].
TOPOL, E ;
CALIFF, R ;
VANDEWERF, F ;
ARMSTRONG, PW ;
AYLWARD, P ;
BARBASH, G ;
BATES, E ;
BETRIU, A ;
BOISSEL, JP ;
CHESEBRO, J ;
COL, J ;
DEBONO, D ;
GORE, J ;
GUERCI, A ;
HAMPTON, J ;
HIRSH, J ;
HOLMES, D ;
HORGAN, J ;
KLEIMAN, N ;
MARDER, V ;
MORRIS, D ;
OHMAN, M ;
PFISTERER, M ;
ROSS, A ;
RUTSCH, W ;
SADOWSKI, Z ;
SIMOONS, M ;
VAHANIAN, A ;
WEAVER, WD ;
WHITE, H ;
WILCOX, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (10) :673-682
[7]   Randomized comparison of Prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention -: Results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trial [J].
Wiviott, SD ;
Antman, EM ;
Winters, KJ ;
Weerakkody, G ;
Murphy, SA ;
Behounek, BD ;
Carney, RJ ;
Lazzam, C ;
McKay, RG ;
McCabe, CH ;
Braunwald, E .
CIRCULATION, 2005, 111 (25) :3366-3373
[8]   Prasugrel versus clopidogrel in patients with acute coronary syndromes [J].
Wiviott, Stephen D. ;
Braunwald, Eugene ;
McCabe, Carolyn H. ;
Montalescot, Gilles ;
Ruzyllo, Witold ;
Gottlieb, Shmuel ;
Neumann, Franz-Joseph ;
Ardissino, Diego ;
De Servi, Stefano ;
Murphy, Sabina A. ;
Riesmeyer, Jeffrey ;
Weerakkody, Govinda ;
Gibson, C. Michael ;
Antman, Elliott M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2001-2015
[9]   Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) [J].
Wiviott, Stephen D. ;
Antman, Elliott M. ;
Gibson, C. Michael ;
Montalescot, Gilles ;
Riesmeyer, Jeffrey ;
Weerakkody, Govinda ;
Winters, Kenneth J. ;
Warmke, Jeffrey W. ;
McCabe, Carolyn H. ;
Braunwald, Eugene .
AMERICAN HEART JOURNAL, 2006, 152 (04) :627-635
1